Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT06432868

Solarplast (R) Supplementation Effects Following High-intensity Resistance Exercise

Sponsor: Kent State University

View on ClinicalTrials.gov

Summary

The primary goal of this investigation is to assess whether Solarplast (R) supplementation will improve recovery following heavy resistance exercise in active adults. The primary questions to be addressed are: Does Solarplast (R) decrease muscle damage and inflammation associated with heavy resistance exercise? Does Solarplast (R) reduce the decline in performance associate with heavy resistance exercise? Researchers will compare Solarplast (R) to a placebo (a look-alike substance that contains no active ingredients) to see if Solarplast (R) is effective at improving recovery. Participants will be asked to: Take Solarplast (R) or placebo daily for 4 weeks Visit the laboratory at least once per week to receive their supplement Report to the lab for 3 consecutive visits following supplementation to complete a heavy resistance training session and follow-up testing.

Official title: Effects of Solarplast (R) Supplementation on Biomarkers of Muscle Damage, Inflammation and Recovery of Physical Performance Following High-intensity Resistance Exercise

Key Details

Gender

All

Age Range

18 Years - 35 Years

Study Type

INTERVENTIONAL

Enrollment

Start Date

2024-04-17

Completion Date

2025-03-31

Last Updated

2024-05-29

Healthy Volunteers

Yes

Conditions

Muscle Damage

Interventions

DIETARY_SUPPLEMENT

Solarplast (R)

Daily supplementation for 28 days prior to heavy resistance exercise.

DIETARY_SUPPLEMENT

Placebo

Daily supplementation for 28 days prior to heavy resistance exercise.

Inclusion Criteria: * Recreationally-active (participated in at least 2 weight training workouts per week over the previous year) and participates in at least 3h of total structured exercise/week as determined by the health and activity questionnaire. * Subject is judged by the Investigator to be healthy and free of any physical limitations (determined by health and activity questionnaire) * Subject has a body mass index of 18.0-34.9 kg/m2, inclusive * Subject is willing to maintain habitual diet throughout the study period * Subject is willing to abstain from dietary supplementation throughout the duration of the study. * Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study Investigators Exclusion Criteria: * Subject is currently or will be enrolled in another clinical trial. * Subject is a habitual consumer of tea/antioxidants defined as \> 8 oz/day of either green or black tea within the 14 days prior to the screening visit. * Subject has a history or presence of a clinically relevant cardiac, renal, hepatic, endocrine (including diabetes mellitus), pulmonary, biliary, gastrointestinal, pancreatic, or neurologic disorder. * Subject has a history or presence of cancer in the prior 2 years, except for non-melanoma skin cancer. * Subject is unable to perform physical exercise (determined by health and activity questionnaire) * Subject is engaged in an extreme diet including but not limited to, Atkins, South Beach, Intermittent Fasting, etc. * Subject is allergic to the study product or placebo * Subject is taking any other nutritional supplement or performance enhancing drug (determined from health and activity questionnaire) * Subject has any chronic illness that causes continuous medical care * Taking any type of prescription or over-the-counter medication including but not limited to corticosteroids, non-steroidal anti-inflammatory drugs, and antibiotics within the 14 days prior to the screening visit.

Locations (1)

Kent State University - Exercise Science & Exercise Physiology

Kent, Ohio, United States